This inventor holds 4 USPTO granted patents. Top assignees: Roche Diagnostics Gmbh, Roche Molecular Systems, Inc.. Active years: 2002-2011.
Company Filing History:
Years Active: 2002-2011
Title: The Innovations of Bernhard Angerer
Introduction
Bernhard Angerer is a notable inventor based in Rosenheim, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of thermostable enzymes. With a total of 4 patents to his name, his work has had a profound impact on various applications in molecular biology.
Latest Patents
Angerer's latest patents focus on purified thermostable enzymes derived from thermophilic archaebacteria. These enzymes can be either native or recombinant and retain approximately 90% of their activity after incubation for two hours at 95°C in the presence of stabilizing agents. They also possess 3'-5' proofreading exonuclease activity, making them particularly useful in recombinant DNA techniques, especially in nucleic acid amplification by the polymerase chain reaction (PCR).
Career Highlights
Throughout his career, Bernhard Angerer has worked with prominent companies in the biotechnology sector, including Roche Molecular Systems, Inc. and Roche Diagnostics GmbH. His expertise in enzyme technology has positioned him as a key figure in the development of innovative solutions for molecular biology applications.
Collaborations
Angerer has collaborated with several esteemed colleagues, including Frank Laue and Gudrun Schmitz-Agheguian. These partnerships have further enhanced his research and development efforts in the field.
Conclusion
Bernhard Angerer is a distinguished inventor whose work in thermostable enzymes has advanced the field of biotechnology. His contributions continue to influence various applications in molecular biology, showcasing the importance of innovation in scientific research.